MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 228 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,550,000 | -55.0% | 50,000 | -52.8% | 0.02% | -56.9% |
| Q1 2023 | $25,679,560 | -28.9% | 106,000 | -14.8% | 0.06% | -32.6% |
| Q4 2022 | $36,104,488 | +6009.1% | 124,391 | +1266.9% | 0.09% | +8500.0% |
| Q3 2022 | $591,000 | -92.2% | 9,100 | -88.2% | 0.00% | -92.9% |
| Q1 2022 | $7,588,000 | -10.5% | 77,331 | -22.7% | 0.01% | -6.7% |
| Q4 2021 | $8,474,000 | +6.2% | 100,000 | 0.0% | 0.02% | -6.2% |
| Q3 2021 | $7,979,000 | -18.1% | 100,000 | 0.0% | 0.02% | -15.8% |
| Q2 2021 | $9,741,000 | +33.6% | 100,000 | +60.5% | 0.02% | +26.7% |
| Q1 2021 | $7,290,000 | +100.1% | 62,323 | +55.8% | 0.02% | +66.7% |
| Q4 2019 | $3,644,000 | -9.2% | 40,000 | +24.8% | 0.01% | -10.0% |
| Q1 2019 | $4,015,000 | -3.9% | 32,050 | -13.5% | 0.01% | -16.7% |
| Q4 2018 | $4,176,000 | -39.2% | 37,050 | +15.6% | 0.01% | -20.0% |
| Q3 2018 | $6,863,000 | -50.9% | 32,050 | -35.9% | 0.02% | -53.1% |
| Q2 2018 | $13,985,000 | -52.1% | 50,000 | -80.0% | 0.03% | -52.9% |
| Q1 2018 | $29,198,000 | -29.5% | 250,000 | -44.6% | 0.07% | -27.7% |
| Q4 2017 | $41,443,000 | +84.3% | 451,500 | -9.7% | 0.09% | +70.9% |
| Q3 2017 | $22,490,000 | +130.5% | 500,000 | -16.7% | 0.06% | +129.2% |
| Q2 2017 | $9,756,000 | +58.4% | 600,000 | +50.0% | 0.02% | +50.0% |
| Q1 2017 | $6,160,000 | +18.1% | 400,000 | +14.3% | 0.02% | +14.3% |
| Q4 2016 | $5,215,000 | – | 350,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
| L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
| Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
| Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
| GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
| ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
| Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
| MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
| Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
| Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |